Journal List > Brain Tumor Res Treat > v.11(4) > 1516084434

Lee, Kim, Park, Kang, and Park: Recurrence of Rathke’s Cleft Cyst Following Surgery and Histopathological Considerations for Recurrence: A Case Presentation

Abstract

Recurrence of Rathke’s cleft cysts (RCC) following surgery is not uncommon. We present a 33-year-old male patient with chronic headache and visual disturbances whose MRI showed mostly cystic, suprasellar mass with peripheral enhancement. Endoscopic extended transsphenoidal approach and tumor resection was performed and RCC was pathologically confirmed postoperatively. Early recurrence was first suspected at 3 months following surgery, and his serial MRIs showed a recurred mass without associated clinical symptoms. Upon further histopathological study, extensive squamous metaplasia and high Ki-67 were seen. Also, in this study, we discuss important factors associated with cyst recurrence following surgery.

INTRODUCTION

Rathke’s cleft cysts (RCC) are benign sellar and/or suprasellar lesions arising from the remnants of the Rathke pouch [1]. Symptomatic RCC presenting with mass effect is usually managed surgically by draining the cyst contents with or without biopsy, while complete removal of the cyst wall is sometimes performed [2]. However, the recurrence of RCC is frequently observed with the reported rates from 0% to 42%, and there is no consensus over the most effective surgical method [34]. Some authors suggest aggressive surgical resection of the entire cyst wall to prevent cyst recurrence, but such an approach has been found to be associated with higher rates of postoperative endocrine dysfunction [56].
The intrinsic characteristics of RCC have been studied by many authors in an attempt to explore factors associated with cyst recurrence. Among them, the presence of squamous metaplasia is widely accepted as the most significant causative factor for recurrence [35678]. In fact, in their long-term follow-up study, Kinoshita et al. [9] suggest that the recurrence of RCC is independently associated with the presence of squamous metaplasia, but not with the surgical procedure.
Recently, a close relationship between aggressive RCC and craniopharyngioma has been suggested, and the possibility that these cystic ectodermal lesions represent a continuum has gained popularity over the last two decades [10]. In this paper, we present a case of recurrent RCC, which was initially thought of as craniopharyngioma, and discuss several relevant factors associated with cyst recurrence, including histological characteristics.

CASE REPORT

A 33-year-old male patient presented with a sudden worsening of headache and visual symptoms for two weeks. His initial MRI showed about 1.8×1.5×2.3 cm sized, mostly cystic, suprasellar mass compressing the optic chiasm. The mass also showed peripheral rim enhancement on contrast-enhanced T1-weighted MRI (Fig. 1). On admission, basal hormone level was checked and visual field analysis was also done, and both results were normal. Based on the preoperative information, suprasellar craniopharyngioma was highly suspected. Tumor removal via endoscopic extended transsphenoidal approach was performed. The tumor consists of mostly yellow mucoid with some solid portions and gross total resection (GTR) was done while preserving the pituitary stalk (Fig. 2). Intraoperative frozen section biopsy favored the diagnosis of craniopharyngioma. Postoperative MRI showed no immediate complications and the patient’s initial symptoms improved and he was discharged at postoperative day 9. Unexpectedly, the final pathological diagnosis confirmed RCC rather than craniopharyngioma (Fig. 3). Outpatient follow-up with MRI was done 3-months postoperatively and a slightly enhancing small suprasellar lesion was seen. His 1-year postoperative MRI explicitly showed recurred cystic mass at the suprasellar area, which was also seen on his 1.5-year postoperative MRI (Fig. 4). Since the patient was asymptomatic, and the size of the recurred mass did not change significantly, close observation with subsequent MRI follow-ups was planned instead of surgical intervention.
Since early recurrence of RCC following surgery seemed unusual, additional histopathological tests were done. To differentiate from craniopharyngioma, BRAF V600E mutation and β-catenin mimmunohistochemical studies were performed and the results were negative. Further histopathological studies showed the presence of squamous metaplasia and high Ki-67 proliferation index (15%) (Fig. 5).

DISCUSSION

RCC are typically asymptomatic, but sometimes present with clinical symptoms such as headache (50%), visual loss (46%–55%), and endocrine dysfunction (70%) [11]. As in our case, symptomatic RCC are usually managed surgically, and several surgical techniques have been utilized in order to treat symptomatic RCC. Radical opening of the cyst wall with full evacuation of the cyst contents was first suggested by Fager and Carter [12] in 1966. In 1984, Baskin and Wilson [13] recommended that simple transsphenoidal drainage and partial removal of the cyst wall is a safe and effective treatment option, and more recently, surgical marsupialization has been employed to drain cyst contents into sphenoid sinus [14]. In order to reduce recurrence, a more aggressive surgical resection is often performed, however, controversy exists on whether GTR is necessary since this radical approach is more frequently associated with postoperative diabetes insipidus and hormonal defects [5611].
Cyst characteristics including inflammation, presence of stratified epithelium, squamous metaplasia, high proliferation index (Ki-67), and cyst wall enhancement on MRI have been suggestive of factors associated with cyst recurrence. Epithelial changes may occur due to repeated intracystic inflammation which could lead to transition from typically single columnar or cuboidal RCC epithelium to stratified, squamous epithelium. When compared to single, columnar epithelium, stratified and squamous epithelium possess higher potential of proliferation and high rate of positive Ki-67 distribution [15]. Above all, the presence of squamous metaplasia has been proposed as the most important risk factor for recurrence [356789]. In fact, RCC with squamous metaplasia show more aggressive nature, and their potential association with craniopharyngioma has been advocated by several authors [101516].
Craniopharyngiomas are relatively common locally aggressive neoplasms that arise from squamous epithelia cell rests occurring anywhere along the craniopharyngeal duct, the canal that connects the stomodeal ectoderm with the invaginating Rathke’s pouch [1718]. In their study, Alomari et al. [10] presented a unique case of a 7-year-old boy whose postoperative pathology showed histologic features of both RCC and craniopharyngioma, suggesting a progressive transformation from RCC to craniopharyngioma [10]. Moreover, in 2014, Ogawa et al. [15] presented a case of a 47-year-old male patient who underwent two consecutive surgeries in 7-month period, due to repeated expansion of a suprasellar cyst. The patient was diagnosed with RCC at the first surgery but was found to be craniopharyngioma after the second surgery which also supports the above viewpoint [12]. Interestingly, both cases showed squamous metaplasia within their RCC components.
In our case, unusual early recurrence of RCC was noted and further molecular and histopathological studies were necessary for accurate diagnosis. Our patient showed negative V600E mutation in the BRAF oncogene which is a well-recognized factor that is identified in 95% of cases of papillary craniopharyngiomas [19]. Moreover, we noted high proliferation index (Ki-67) of 15% which also suggests more aggressive tumor nature and potential recurrence in the future. We believe further studies on the molecular pathogenesis of these lesions are required to clarify underlying mechanism of cyst progression. Unfortunately, it is difficult to predict whether the cyst will show aggressive nature or not until postoperative histologic characteristics are revealed. As in our case, intraoperative frozen biopsy could misdiagnose RCC with craniopharyngioma. Therefore, the presence of rim enhancement on preoperative contrast-enhanced MRI could be an important finding which may suggest inflammation, vessel proliferation, and recurrence potential, as proposed by several authors [711].
This case report of recurrent RCC provides additional support to current understanding of factors associated with aggressive nature RCC. Patients with symptomatic RCC whose histopathological studies show squamous metaplasia and high proliferation index (Ki-67) should be closely followed postoperatively and cyst wall enhancement on contrast MRI may provide valuable information regarding recurrence potential of the cyst.

Notes

Ethics Statement: The informed consent was recieved from the patient and there are no experimental procedures involving human or animal subjects.

Author Contributions:

  • Conceptualization: Dongwook Lee, Kyung-Jae Park.

  • Formal analysis: Shin-Hyuk Kang, Dong-Hyuk Park.

  • Investigation: Dongwook Lee, Jang Hun Kim.

  • Methodology: Kyung-Jae Park.

  • Project administration: Shin-Hyuk Kang, Kyung-Jae Park.

  • Supervision: Shin-Hyuk Kang, Kyung-Jae Park.

  • Validation: Kyung-Jae Park.

  • Visualization: Dongwook Lee, Jang Hun Kim.

  • Writing—original draft: Dongwook Lee.

  • Writing—review & editing: Dongwook Lee, Kyung-Jae Park.

Conflicts of Interest: Shin-Hyuk Kang, a contributing editor of Brain Tumor Research and Treatment, was not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.

Funding Statement: None

Availability of Data and Material

Data sharing not applicable to this article as no datasets were generated or analyzed during the study.

References

1. Iannelli A, Martini C, Cosottini M, Castagna M, Bogazzi F, Muscatello L. Rathke’s cleft cysts in children: clinical, diagnostic, and surgical features. Childs Nerv Syst. 2012; 28:297–303. PMID: 22057478.
crossref
2. Han SJ, Rolston JD, Jahangiri A, Aghi MK. Rathke’s cleft cysts: review of natural history and surgical outcomes. J Neurooncol. 2014; 117:197–203. PMID: 24146189.
crossref
3. El-Mahdy W, Powell M. Transsphenoidal management of 28 symptomatic Rathke’s cleft cysts, with special reference to visual and hormonal recovery. Neurosurgery. 1998; 42:7–17. PMID: 9442498.
crossref
4. Raper DM, Besser M. Clinical features, management and recurrence of symptomatic Rathke’s cleft cyst. J Clin Neurosci. 2009; 16:385–389. PMID: 19147363.
crossref
5. Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH. Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg. 2005; 102:189–193.
crossref
6. Benveniste RJ, King WA, Walsh J, Lee JS, Naidich TP, Post KD. Surgery for Rathke cleft cysts: technical considerations and outcomes. J Neurosurg. 2004; 101:577–584. PMID: 15481709.
crossref
7. Kim JE, Kim JH, Kim OL, Paek SH, Kim DG, Chi JG, et al. Surgical treatment of symptomatic Rathke cleft cysts: clinical features and results with special attention to recurrence. J Neurosurg. 2004; 100:33–40. PMID: 14743909.
crossref
8. Wait SD, Garrett MP, Little AS, Killory BD, White WL. Endocrinopathy, vision, headache, and recurrence after transsphenoidal surgery for Rathke cleft cysts. Neurosurgery. 2010; 67:837–843. PMID: 20657318.
crossref
9. Kinoshita Y, Tominaga A, Usui S, Arita K, Sakoguchi T, Sugiyama K, et al. The long-term recurrence of Rathke’s cleft cysts as predicted by histology but not by surgical procedure. J Neurosurg. 2016; 125:1002–1007. PMID: 26771852.
crossref
10. Alomari AK, Kelley BJ, Damisah E, Marks A, Hui P, DiLuna M, et al. Craniopharyngioma arising in a Rathke’s cleft cyst: case report. J Neurosurg Pediatr. 2015; 15:250–254. PMID: 25555112.
crossref
11. Mendelson ZS, Husain Q, Elmoursi S, Svider PF, Eloy JA, Liu JK. Rathke’s cleft cyst recurrence after transsphenoidal surgery: a meta-analysis of 1151 cases. J Clin Neurosci. 2014; 21:378–385. PMID: 24269553.
crossref
12. Fager CA, Carter H. Intrasellar epithelial cysts. J Neurosurg. 1966; 24:77–81. PMID: 5903300.
crossref
13. Baskin DS, Wilson CB. Transsphenoidal treatment of non-neoplastic intrasellar cysts. A report of 38 cases. J Neurosurg. 1984; 60:8–13. PMID: 6689730.
14. Kuan EC, Yoo F, Chyu J, Bergsneider M, Wang MB. Treatment outcomes of Rathke’s cleft cysts managed with marsupialization. J Neurol Surg B Skull Base. 2017; 78:112–115. PMID: 28321372.
crossref
15. Ogawa Y, Watanabe M, Tominaga T. Spontaneous alteration from Rathke’s cleft cyst to craniopharyngioma--possible involvement of transformation between these pathologies. Endocr Pathol. 2014; 25:422–426. PMID: 25154633.
crossref
16. Schlaffer SM, Buchfelder M, Stoehr R, Buslei R, Hölsken A. Rathke’s cleft cyst as origin of a pediatric papillary craniopharyngioma. Front Genet. 2018; 9:49. PMID: 29520296.
crossref
17. Park YS, Ahn JY, Kim DS, Kim TS, Kim SH. Late development of craniopharyngioma following surgery for Rathke’s cleft cyst. Clin Neuropathol. 2009; 28:177–181. PMID: 19537134.
crossref
18. Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010; 28:E4.
crossref
19. Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014; 46:161–165. PMID: 24413733.
Fig. 1

Initial contrast-enhanced MRI showing suprasellar mass with peripheral enhancement.

btrt-11-266-g001
Fig. 2

Intraoperative endoscopic view. Yellow mucoid tumor contents were seen.

btrt-11-266-g002
Fig. 3

H&E-stained section showing ciliated columnar epithelium suggestive of Rathke’s cleft cyst (×200).

btrt-11-266-g003
Fig. 4

Serial postoperative MRI follow-ups. A: Postoperative 48 hours. B: Cyst recurrence was suspected at 3 months (red arrow). C and D: Postoperative 12 and 18 months, respectively; cyst recurrence became more evident without interval size change (red circle).

btrt-11-266-g004
Fig. 5

Histological characterization and immunohistochemical stainings. A: H&E staining showed extensive squamous metaplasia (×200). B: BRAF V600E mutation was negative (×200). C: Ki-67 index result was 15% (×150).

btrt-11-266-g005
TOOLS
Similar articles